n-(4-(4-maleimidophenyl)butyryl)phosphatidylethanolamine has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Jong, WH; Jap, PH; Nässander, UK; Poels, LG; Steerenberg, PA; Storm, G; Te Boekhorst, CM; Van Overveld, WO | 1 |
1 other study(ies) available for n-(4-(4-maleimidophenyl)butyryl)phosphatidylethanolamine and Ovarian Neoplasms
Article | Year |
---|---|
Design of immunoliposomes directed against human ovarian carcinoma.
Topics: Animals; Antibodies, Neoplasm; Antigen-Antibody Reactions; Antigens, Neoplasm; Female; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phosphatidylethanolamines; Tumor Cells, Cultured | 1995 |